I agree.
If the Israeli trials are not exceptional
the company reverts to life as an early stage preclinical company given neither FTO or Cardioprotection are anywhere near First in Patient trials. Value will then be in the 10’s of millions not in the 100’s (not accounting for the bank balance).
Pivotal period for the company.
I agree. If the Israeli trials are not exceptional the company...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.015(1.21%) |
Mkt cap ! $204.3M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.21 | $119.0K | 96.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2509 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 2409 | 1 |
View Market Depth
| Last trade - 15.14pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.22 |
Change
-0.015 ( 1.61 %) |
||||
| Open | High | Low | Volume | ||
| $1.24 | $1.25 | $1.21 | 15053 | ||
| Last updated 15.12pm 02/05/2024 ? | |||||
| RAC (ASX) Chart |